| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF430 ZNF708 ZBTB49 ZNF492 ZSCAN5B ZNF211 ZNF718 ZNF460 PATZ1 ZNF253 ZNF735 ZNF485 ZNF267 ZNF816 ZBTB47 ZNF814 ZNF534 ZNF479 ZNF480 ZNF880 NR5A1 ZNF860 ZNF251 ZNF840P ZNF681 ZNF77 | 1.12e-10 | 1412 | 86 | 26 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF430 ZNF708 ZBTB49 ZNF492 ZSCAN5B ZNF211 ZNF718 ZNF460 PATZ1 ZNF253 ZNF735 ZNF485 ZNF267 ZNF816 ZNF814 ZNF534 ZNF479 ZNF480 ZNF880 NR5A1 ZNF860 ZNF251 ZNF840P ZNF681 | 2.78e-10 | 1244 | 86 | 24 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF430 ZNF708 ZBTB49 ZNF492 ZSCAN5B ZNF211 ZNF718 ZNF460 PATZ1 ZNF253 ZNF735 ZNF485 ZNF267 ZNF816 ZNF814 ZNF534 ZNF479 ZNF480 ZNF880 NR5A1 ZNF860 ZNF251 ZNF840P ZNF681 | 4.29e-10 | 1271 | 86 | 24 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF430 ZNF708 ZBTB49 ZNF492 ZSCAN5B ZNF211 ZNF718 ZNF460 PATZ1 ZNF253 ZNF735 ZNF485 ZNF267 ZNF816 ZNF814 ZNF534 ZNF479 ZNF480 ZNF880 NR5A1 ZNF860 ZNF251 ZNF840P ZNF681 ZNF77 | 1.27e-09 | 1459 | 86 | 25 | GO:0000977 |
| GeneOntologyMolecularFunction | peptide-glutamate-alpha-N-acetyltransferase activity | 1.83e-05 | 2 | 86 | 2 | GO:1990190 | |
| GeneOntologyMolecularFunction | adenosine-phosphate deaminase activity | 5.48e-05 | 3 | 86 | 2 | GO:0047623 | |
| GeneOntologyMolecularFunction | AMP deaminase activity | 5.48e-05 | 3 | 86 | 2 | GO:0003876 | |
| GeneOntologyMolecularFunction | peptide-serine-alpha-N-acetyltransferase activity | 5.48e-05 | 3 | 86 | 2 | GO:1990189 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 1.82e-04 | 5 | 86 | 2 | GO:0004558 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | 3.15e-04 | 137 | 86 | 5 | GO:0019783 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 3.80e-04 | 7 | 86 | 2 | GO:0090599 | |
| GeneOntologyMolecularFunction | peptide alpha-N-acetyltransferase activity | 5.05e-04 | 8 | 86 | 2 | GO:0004596 | |
| GeneOntologyMolecularFunction | siRNA binding | 1.18e-03 | 12 | 86 | 2 | GO:0035197 | |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | 1.45e-03 | 192 | 86 | 5 | GO:0008234 | |
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | 1.49e-03 | 114 | 86 | 4 | GO:0004843 | |
| GeneOntologyMolecularFunction | glucosidase activity | 1.86e-03 | 15 | 86 | 2 | GO:0015926 | |
| GeneOntologyMolecularFunction | deubiquitinase activity | 2.03e-03 | 124 | 86 | 4 | GO:0101005 | |
| GeneOntologyCellularComponent | NatA complex | 1.66e-04 | 5 | 86 | 2 | GO:0031415 | |
| Domain | KRAB | ZNF430 ZNF708 ZNF492 ZNF211 ZNF718 ZNF460 ZNF253 ZNF735 ZNF485 ZNF267 ZNF816 ZNF814 ZNF534 ZNF479 ZNF480 ZNF880 ZNF860 ZNF251 ZNF681 ZNF77 | 1.19e-16 | 358 | 85 | 20 | PS50805 |
| Domain | KRAB | ZNF430 ZNF708 ZNF492 ZNF211 ZNF718 ZNF460 ZNF253 ZNF735 ZNF485 ZNF267 ZNF816 ZNF814 ZNF534 ZNF479 ZNF480 ZNF880 ZNF860 ZNF251 ZNF681 ZNF77 | 1.19e-16 | 358 | 85 | 20 | PF01352 |
| Domain | zf-C2H2_6 | ZBTB49 ZNF492 ZSCAN5B ZNF211 ZNF718 PATZ1 ZNF253 ZNF735 ZNF267 ZNF816 ZBTB47 ZNF814 ZNF479 ZNF480 ZNF880 ZNF860 ZNF251 ZNF681 ZNF77 | 1.76e-16 | 314 | 85 | 19 | PF13912 |
| Domain | - | ZNF430 ZNF708 ZBTB49 ZNF492 ZSCAN5B ZNF211 ZNF718 ZNF460 PATZ1 ZNF253 ZNF735 ZNF485 ZNF267 ZNF816 ZBTB47 ZNF814 ZNF534 ZNF479 ZNF480 ZNF880 ZNF860 ZNF831 ZNF251 ZNF681 ZNF77 | 1.87e-16 | 679 | 85 | 25 | 3.30.160.60 |
| Domain | KRAB | ZNF430 ZNF708 ZNF492 ZNF211 ZNF718 ZNF460 ZNF253 ZNF735 ZNF485 ZNF267 ZNF816 ZNF814 ZNF534 ZNF479 ZNF480 ZNF880 ZNF860 ZNF251 ZNF681 ZNF77 | 2.14e-16 | 369 | 85 | 20 | SM00349 |
| Domain | KRAB | ZNF430 ZNF708 ZNF492 ZNF211 ZNF718 ZNF460 ZNF253 ZNF735 ZNF485 ZNF267 ZNF816 ZNF814 ZNF534 ZNF479 ZNF480 ZNF880 ZNF860 ZNF251 ZNF681 ZNF77 | 2.26e-16 | 370 | 85 | 20 | IPR001909 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF430 ZNF708 ZBTB49 ZNF492 ZSCAN5B ZNF211 ZNF718 ZNF460 PATZ1 ZNF253 ZNF735 ZNF485 ZNF267 ZNF816 ZBTB47 ZNF814 ZNF534 ZNF479 ZNF480 ZNF880 ZNF860 ZNF831 ZNF251 ZNF681 ZNF77 | 3.11e-16 | 694 | 85 | 25 | IPR013087 |
| Domain | zf-C2H2 | ZNF430 ZNF708 ZBTB49 ZNF492 ZSCAN5B ZNF211 ZNF718 ZNF460 PATZ1 ZNF253 ZNF735 ZNF485 ZNF267 ZNF816 ZBTB47 ZNF814 ZNF534 ZNF479 ZNF480 ZNF880 ZNF860 ZNF251 ZNF681 ZNF77 | 3.32e-15 | 693 | 85 | 24 | PF00096 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF430 ZNF708 ZBTB49 ZNF492 ZSCAN5B ZNF211 ZNF718 ZNF460 PATZ1 ZNF253 ZNF735 ZNF485 ZNF267 ZNF816 ZBTB47 ZNF814 ZNF534 ZNF479 ZNF480 ZNF880 ZNF860 ZNF831 ZNF251 ZNF681 ZNF77 | 3.97e-15 | 775 | 85 | 25 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF430 ZNF708 ZBTB49 ZNF492 ZSCAN5B ZNF211 ZNF718 ZNF460 PATZ1 ZNF253 ZNF735 ZNF485 ZNF267 ZNF816 ZBTB47 ZNF814 ZNF534 ZNF479 ZNF480 ZNF880 ZNF860 ZNF831 ZNF251 ZNF681 ZNF77 | 4.21e-15 | 777 | 85 | 25 | PS00028 |
| Domain | Znf_C2H2-like | ZNF430 ZNF708 ZBTB49 ZNF492 ZSCAN5B ZNF211 ZNF718 ZNF460 PATZ1 ZNF253 ZNF735 ZNF485 ZNF267 ZNF816 ZBTB47 ZNF814 ZNF534 ZNF479 ZNF480 ZNF880 ZNF860 ZNF831 ZNF251 ZNF681 ZNF77 | 7.32e-15 | 796 | 85 | 25 | IPR015880 |
| Domain | Znf_C2H2 | ZNF430 ZNF708 ZBTB49 ZNF492 ZSCAN5B ZNF211 ZNF718 ZNF460 PATZ1 ZNF253 ZNF735 ZNF485 ZNF267 ZNF816 ZBTB47 ZNF814 ZNF534 ZNF479 ZNF480 ZNF880 ZNF860 ZNF831 ZNF251 ZNF681 ZNF77 | 9.46e-15 | 805 | 85 | 25 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF430 ZNF708 ZBTB49 ZNF492 ZSCAN5B ZNF211 ZNF718 ZNF460 PATZ1 ZNF253 ZNF735 ZNF485 ZNF267 ZNF816 ZBTB47 ZNF814 ZNF534 ZNF479 ZNF480 ZNF880 ZNF860 ZNF831 ZNF251 ZNF681 ZNF77 | 1.03e-14 | 808 | 85 | 25 | SM00355 |
| Domain | AMPD | 6.12e-05 | 3 | 85 | 2 | IPR006329 | |
| Domain | A/AMP_deam_AS | 1.22e-04 | 4 | 85 | 2 | IPR006650 | |
| Domain | A_deaminase | 3.03e-04 | 6 | 85 | 2 | PF00962 | |
| Domain | Glyco_hydro_31_AS | 3.03e-04 | 6 | 85 | 2 | IPR030458 | |
| Domain | A_DEAMINASE | 3.03e-04 | 6 | 85 | 2 | PS00485 | |
| Domain | A/AMP_deaminase_dom | 3.03e-04 | 6 | 85 | 2 | IPR001365 | |
| Domain | Glyco_hydro_31 | 4.24e-04 | 7 | 85 | 2 | IPR000322 | |
| Domain | Glyco_hydro_31 | 4.24e-04 | 7 | 85 | 2 | PF01055 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 4.24e-04 | 7 | 85 | 2 | PS00129 | |
| Domain | BTB | 1.38e-03 | 180 | 85 | 5 | SM00225 | |
| Domain | TTL | 1.55e-03 | 13 | 85 | 2 | PS51221 | |
| Domain | TTL/TTLL_fam | 1.55e-03 | 13 | 85 | 2 | IPR004344 | |
| Domain | TTL | 1.55e-03 | 13 | 85 | 2 | PF03133 | |
| Domain | BTB/POZ_dom | 1.56e-03 | 185 | 85 | 5 | IPR000210 | |
| Domain | SKP1/BTB/POZ | 1.72e-03 | 189 | 85 | 5 | IPR011333 | |
| Domain | Gal_mutarotase_SF_dom | 2.66e-03 | 17 | 85 | 2 | IPR011013 | |
| Domain | USP_CS | 3.39e-03 | 66 | 85 | 3 | IPR018200 | |
| Domain | USP_1 | 4.00e-03 | 70 | 85 | 3 | PS00972 | |
| Domain | UCH | 4.16e-03 | 71 | 85 | 3 | PF00443 | |
| Domain | USP_2 | 4.16e-03 | 71 | 85 | 3 | PS00973 | |
| Domain | USP_3 | 4.33e-03 | 72 | 85 | 3 | PS50235 | |
| Domain | USP_dom | 4.33e-03 | 72 | 85 | 3 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 4.33e-03 | 72 | 85 | 3 | IPR001394 | |
| Domain | Acetyltransf_1 | 4.87e-03 | 23 | 85 | 2 | PF00583 | |
| Domain | Spectrin | 4.87e-03 | 23 | 85 | 2 | PF00435 | |
| Domain | Metal_Hydrolase | 5.29e-03 | 24 | 85 | 2 | IPR032466 | |
| Domain | GNAT | 5.74e-03 | 25 | 85 | 2 | PS51186 | |
| Domain | GNAT_dom | 5.74e-03 | 25 | 85 | 2 | IPR000182 | |
| Domain | EFh | 5.87e-03 | 158 | 85 | 4 | SM00054 | |
| Domain | BTB | 6.14e-03 | 160 | 85 | 4 | PS50097 | |
| Pubmed | ZNF430 ZNF708 ZNF211 ZNF718 ZNF460 ZNF253 ZNF485 ZNF267 ZNF480 ZNF681 ZNF77 | 1.26e-12 | 181 | 88 | 11 | 37372979 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 15203214 | ||
| Pubmed | Increased Th1 immune response in SERPINB3 transgenic mice during acute liver failure. | 6.33e-06 | 2 | 88 | 2 | 23354406 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 19246321 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 22406480 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 23911318 | ||
| Pubmed | Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy. | 6.33e-06 | 2 | 88 | 2 | 27668655 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 10520747 | ||
| Pubmed | Characterization of novel squamous cell carcinoma antigen-related molecules in mice. | 6.33e-06 | 2 | 88 | 2 | 15504361 | |
| Pubmed | SCCA2-like serpins mediate genetic predisposition to skin tumors. | 6.33e-06 | 2 | 88 | 2 | 12702576 | |
| Pubmed | Serpinb3 is overexpressed in the liver in presence of iron overload. | 6.33e-06 | 2 | 88 | 2 | 28935635 | |
| Pubmed | Lysoptosis is an evolutionarily conserved cell death pathway moderated by intracellular serpins. | 6.33e-06 | 2 | 88 | 2 | 35022507 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 29088270 | ||
| Pubmed | Overexpression of SERPIN B3 promotes epithelial proliferation and lung fibrosis in mice. | 6.33e-06 | 2 | 88 | 2 | 21403642 | |
| Pubmed | AMP deaminase 3 plays a critical role in remote reperfusion lung injury. | 6.33e-06 | 2 | 88 | 2 | 23542464 | |
| Pubmed | Identification of a novel human member of the DEAD box protein family. | 6.33e-06 | 2 | 88 | 2 | 10727850 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 25111616 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 11267667 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 17878374 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 29491058 | ||
| Pubmed | Squamous cell carcinoma antigen production in nasal inverted papilloma. | 6.33e-06 | 2 | 88 | 2 | 23168150 | |
| Pubmed | The serpin SQN-5 is a dual mechanistic-class inhibitor of serine and cysteine proteinases. | 6.33e-06 | 2 | 88 | 2 | 11863458 | |
| Pubmed | IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease. | 6.33e-06 | 2 | 88 | 2 | 22808225 | |
| Pubmed | Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. | 6.33e-06 | 2 | 88 | 2 | 14970861 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 10653592 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 29112685 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 10956412 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 20428762 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 35874657 | ||
| Pubmed | Serpin B3/B4, activated by STAT3, promote survival of squamous carcinoma cells. | 1.90e-05 | 3 | 88 | 2 | 19070595 | |
| Pubmed | Naa12 compensates for Naa10 in mice in the amino-terminal acetylation pathway. | 1.90e-05 | 3 | 88 | 2 | 34355692 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 1400401 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 7287721 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 9828132 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 22451727 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 7724531 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 24898082 | ||
| Pubmed | A nonredundant role for mouse Serpinb3a in the induction of mucus production in asthma. | 1.90e-05 | 3 | 88 | 2 | 21126757 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 9857047 | ||
| Pubmed | SOX7 inhibits the malignant progression of bladder cancer via the DNMT3B/CYGB axis. | 1.90e-05 | 3 | 88 | 2 | 39227479 | |
| Pubmed | Molecular cloning of AMP deaminase isoform L. Sequence and bacterial expression of human AMPD2 cDNA. | 1.90e-05 | 3 | 88 | 2 | 1429593 | |
| Pubmed | Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC). | 1.90e-05 | 3 | 88 | 2 | 24635038 | |
| Pubmed | Heparin enhances serpin inhibition of the cysteine protease cathepsin L. | 1.90e-05 | 3 | 88 | 2 | 19959474 | |
| Pubmed | Uteroglobin suppresses SCCA gene expression associated with allergic asthma. | 1.90e-05 | 3 | 88 | 2 | 15677460 | |
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 24459426 | ||
| Pubmed | Impact of viral and host DNA methylations on HPV16-related cervical cancer pathogenesis. | 3.79e-05 | 4 | 88 | 2 | 28459195 | |
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 16549498 | ||
| Pubmed | Inhibitory mechanism of a cross-class serpin, the squamous cell carcinoma antigen 1. | 3.79e-05 | 4 | 88 | 2 | 12949073 | |
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 21576355 | ||
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 16286015 | ||
| Pubmed | A novel human NatA Nalpha-terminal acetyltransferase complex: hNaa16p-hNaa10p (hNat2-hArd1). | 6.30e-05 | 5 | 88 | 2 | 19480662 | |
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 16638120 | ||
| Pubmed | 9.43e-05 | 6 | 88 | 2 | 29079593 | ||
| Pubmed | Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II. | 9.43e-05 | 6 | 88 | 2 | 18157120 | |
| Pubmed | αv Integrins combine with LC3 and atg5 to regulate Toll-like receptor signalling in B cells. | 1.75e-04 | 8 | 88 | 2 | 26965188 | |
| Pubmed | 2.25e-04 | 9 | 88 | 2 | 20540774 | ||
| Pubmed | A conserved acetylation switch enables pharmacological control of tubby-like protein stability. | 2.63e-04 | 223 | 88 | 5 | 33187986 | |
| Pubmed | Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. | 2.81e-04 | 10 | 88 | 2 | 11923871 | |
| Pubmed | 2.81e-04 | 10 | 88 | 2 | 20569692 | ||
| Pubmed | 2.81e-04 | 10 | 88 | 2 | 18378686 | ||
| Pubmed | 3.43e-04 | 11 | 88 | 2 | 15203215 | ||
| Pubmed | A synopsis of eukaryotic Nalpha-terminal acetyltransferases: nomenclature, subunits and substrates. | 4.11e-04 | 12 | 88 | 2 | 19660095 | |
| Pubmed | TLR4/MD-2 activation by a synthetic agonist with no similarity to LPS. | 4.11e-04 | 12 | 88 | 2 | 26831104 | |
| Pubmed | 4.11e-04 | 12 | 88 | 2 | 23518926 | ||
| Pubmed | 4.11e-04 | 12 | 88 | 2 | 28949961 | ||
| Pubmed | Polymorphisms in interleukin-1 receptor-associated kinase 4 are associated with total serum IgE. | 4.11e-04 | 12 | 88 | 2 | 19254290 | |
| Pubmed | 4.85e-04 | 13 | 88 | 2 | 30108181 | ||
| Pubmed | A targeted multienzyme mechanism for selective microtubule polyglutamylation. | 4.85e-04 | 13 | 88 | 2 | 17499049 | |
| Pubmed | 4.85e-04 | 13 | 88 | 2 | 12935356 | ||
| Pubmed | 4.85e-04 | 13 | 88 | 2 | 11863365 | ||
| Pubmed | 4.85e-04 | 13 | 88 | 2 | 23961995 | ||
| Pubmed | Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1. | 4.85e-04 | 13 | 88 | 2 | 12434312 | |
| Pubmed | 5.57e-04 | 63 | 88 | 3 | 20301682 | ||
| Pubmed | 5.65e-04 | 14 | 88 | 2 | 14625308 | ||
| Pubmed | Photocaged Cell-Permeable Ubiquitin Probe for Temporal Profiling of Deubiquitinating Enzymes. | 5.83e-04 | 64 | 88 | 3 | 33141564 | |
| Pubmed | 5.98e-04 | 407 | 88 | 6 | 12693553 | ||
| Pubmed | 6.51e-04 | 15 | 88 | 2 | 21045126 | ||
| Pubmed | Deubiquitinating enzymes: a new class of biological regulators. | 6.51e-04 | 15 | 88 | 2 | 9827704 | |
| Pubmed | 6.51e-04 | 15 | 88 | 2 | 19576795 | ||
| Pubmed | TET2 catalyzes active DNA demethylation of the Sry promoter and enhances its expression. | 6.51e-04 | 15 | 88 | 2 | 31530896 | |
| Pubmed | EHMT2 directs DNA methylation for efficient gene silencing in mouse embryos. | 6.51e-04 | 15 | 88 | 2 | 26576615 | |
| Pubmed | 6.51e-04 | 15 | 88 | 2 | 30704515 | ||
| Pubmed | Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders. | 6.51e-04 | 15 | 88 | 2 | 24482476 | |
| Pubmed | 7.42e-04 | 16 | 88 | 2 | 16024789 | ||
| Pubmed | A strategy for modulation of enzymes in the ubiquitin system. | 8.40e-04 | 17 | 88 | 2 | 23287719 | |
| Pubmed | TMEM79/MATTRIN defines a pathway for Frizzled regulation and is required for Xenopus embryogenesis. | 9.43e-04 | 18 | 88 | 2 | 32924931 | |
| Pubmed | 9.63e-04 | 76 | 88 | 3 | 10574461 | ||
| Pubmed | Toll-like receptor signaling pathway variants and prostate cancer mortality. | 1.05e-03 | 19 | 88 | 2 | 19505919 | |
| Pubmed | 1.17e-03 | 20 | 88 | 2 | 7479878 | ||
| Pubmed | 1.17e-03 | 20 | 88 | 2 | 2542606 | ||
| Pubmed | 1.29e-03 | 21 | 88 | 2 | 7865130 | ||
| Pubmed | 1.41e-03 | 22 | 88 | 2 | 22902628 | ||
| Pubmed | 1.41e-03 | 22 | 88 | 2 | 34905510 | ||
| Pubmed | TTLL12 USP8 VSNL1 MTA3 SYNE1 ZBTB47 USP9Y ZNF251 USP47 VCPIP1 | 1.52e-03 | 1285 | 88 | 10 | 35914814 | |
| Pubmed | A genomic analysis of rat proteases and protease inhibitors. | 1.55e-03 | 23 | 88 | 2 | 15060002 | |
| Pubmed | 1.60e-03 | 493 | 88 | 6 | 15368895 | ||
| Pubmed | Isoform-specific GSK3A activity is negatively correlated with human sperm motility. | 1.67e-03 | 92 | 88 | 3 | 30824926 | |
| Pubmed | Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. | 1.80e-03 | 342 | 88 | 5 | 23128233 | |
| Pubmed | Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. | 1.83e-03 | 25 | 88 | 2 | 19898481 | |
| Pubmed | 1.83e-03 | 25 | 88 | 2 | 25661788 | ||
| Interaction | FBLN5 interactions | 3.62e-07 | 159 | 85 | 8 | int:FBLN5 | |
| Interaction | LTBP2 interactions | 1.58e-06 | 85 | 85 | 6 | int:LTBP2 | |
| Interaction | TRIM28 interactions | TTLL12 ZNF430 ZNF708 ZNF492 ZNF211 SLC25A12 KCTD13 ZNF718 ZNF460 ZNF253 ZNF485 ZNF267 ZNF816 ZNF480 CUL7 ZNF681 ZNF77 VCPIP1 DNMT3B | 9.41e-06 | 1474 | 85 | 19 | int:TRIM28 |
| Interaction | TIMM50 interactions | 1.45e-05 | 261 | 85 | 8 | int:TIMM50 | |
| Interaction | ZNF460 interactions | 2.59e-05 | 138 | 85 | 6 | int:ZNF460 | |
| Interaction | FMOD interactions | 3.52e-05 | 44 | 85 | 4 | int:FMOD | |
| Cytoband | 19q13.41 | 1.61e-05 | 78 | 88 | 4 | 19q13.41 | |
| Cytoband | 19p12 | 2.84e-05 | 90 | 88 | 4 | 19p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | 9.31e-05 | 122 | 88 | 4 | chr19p12 | |
| Cytoband | 18q21.3 | 1.98e-04 | 11 | 88 | 2 | 18q21.3 | |
| Cytoband | 15q15.2 | 4.28e-04 | 16 | 88 | 2 | 15q15.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ZSCAN5B DPY19L3 ZNF211 ZNF460 ZNF816 ZNF814 ZNF534 ZNF480 ZNF880 | 4.74e-04 | 1192 | 88 | 9 | chr19q13 |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF430 ZNF708 ZBTB49 ZNF492 ZSCAN5B ZNF211 ZNF718 ZNF460 PATZ1 ZNF253 ZNF735 ZNF485 ZNF267 ZNF816 ZBTB47 ZNF814 ZNF534 ZNF479 ZNF480 ZNF880 ZNF860 ZNF251 ZNF681 ZNF77 | 4.69e-17 | 718 | 68 | 24 | 28 |
| GeneFamily | Adenosine deaminase family | 2.07e-04 | 6 | 68 | 2 | 1302 | |
| GeneFamily | N(alpha)-acetyltransferase subunits|GCN5 related N-acetyltransferases | 8.98e-04 | 12 | 68 | 2 | 660 | |
| GeneFamily | Ubiquitin specific peptidases | 1.22e-03 | 56 | 68 | 3 | 366 | |
| GeneFamily | Tubulin tyrosine ligase family | 1.23e-03 | 14 | 68 | 2 | 779 | |
| GeneFamily | GCN5 related N-acetyltransferases | 3.65e-03 | 24 | 68 | 2 | 1134 | |
| GeneFamily | Serpin peptidase inhibitors | 8.53e-03 | 37 | 68 | 2 | 739 | |
| GeneFamily | EF-hand domain containing | 9.32e-03 | 219 | 68 | 4 | 863 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.09e-07 | 166 | 87 | 6 | c4f7ea1cad962b1d6ad77423d15978b68a0d6f1d | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-06 | 172 | 87 | 6 | a9e13aa36087170dadca421ba9de588e5a1cf715 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.99e-06 | 190 | 87 | 6 | 17829f4de31b3d9e4d71ba4817d18842aa699773 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.06e-06 | 143 | 87 | 5 | d877d914e4e74db2053baa310d318d6440e672bc | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.40e-05 | 175 | 87 | 5 | f3a68aeb79c4935006e17a5ff3445a8ec0e33f5f | |
| ToppCell | 18-Distal-Epithelial-Multiciliated_precursor|Distal / Age, Tissue, Lineage and Cell class | 3.21e-05 | 186 | 87 | 5 | 58ab1360a1730655a5939295ba05997ac4a2d14e | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 3.47e-05 | 189 | 87 | 5 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.74e-05 | 192 | 87 | 5 | 55f95454399fd533df75db06584eaa48d6ee3830 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.74e-05 | 192 | 87 | 5 | 5000440dc1ed17e7474d340921bdff945646f27e | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.93e-05 | 194 | 87 | 5 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.22e-05 | 197 | 87 | 5 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.22e-05 | 197 | 87 | 5 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.54e-05 | 200 | 87 | 5 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.54e-05 | 200 | 87 | 5 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| Drug | NSC623156 | 1.03e-06 | 6 | 86 | 3 | CID000360780 | |
| Disease | Ogden syndrome (implicated_via_orthology) | 7.82e-06 | 2 | 83 | 2 | DOID:0050781 (implicated_via_orthology) | |
| Disease | pontocerebellar hypoplasia (implicated_via_orthology) | 7.77e-05 | 5 | 83 | 2 | DOID:0060264 (implicated_via_orthology) | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 9.03e-04 | 67 | 83 | 3 | EFO_0008595, EFO_0020946 | |
| Disease | blood aluminium measurement | 1.44e-03 | 20 | 83 | 2 | EFO_0007575 | |
| Disease | blood pressure | 1.74e-03 | 22 | 83 | 2 | EFO_0004325 | |
| Disease | primary biliary cholangitis (is_marker_for) | 2.25e-03 | 25 | 83 | 2 | DOID:12236 (is_marker_for) | |
| Disease | mean arterial pressure, alcohol drinking | 2.69e-03 | 98 | 83 | 3 | EFO_0004329, EFO_0006340 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NKFYNVHFSNKLPAR | 756 | Q8NDB2 | |
| VKLLHNRSNNKYSYT | 171 | Q8WZ19 | |
| QHKCFTSYRFKSLKQ | 326 | Q6P461 | |
| HFNLATFNKLVSYRK | 286 | Q9UBC3 | |
| KQQSQYRRKLFDASH | 1356 | Q9UIF8 | |
| LNAFLYRTGQHSNKF | 481 | Q9NVI7 | |
| SKYAFARTVNKLNHA | 106 | A0A1B0GW35 | |
| VFQNKTFHVYKLSRN | 701 | Q6ZPD9 | |
| RNTFHRFDKFNAKYN | 481 | Q01433 | |
| RFKNKAYLLQAFTHA | 1676 | Q9UPY3 | |
| ISRKHYKQIAQAAFN | 376 | Q8ND07 | |
| ANFSSDRAFHTFKKQ | 441 | Q8IWY9 | |
| QTFHRFDKFNSKYNP | 381 | Q01432 | |
| ASKFAQHAFRTFDKN | 61 | Q9UM19 | |
| YSAVKSRQFLQFFHK | 276 | Q9NWR8 | |
| YQTSNRFHFKITDFN | 131 | Q2M2H8 | |
| KEYTSNVFLQGKRFH | 166 | Q9BQP7 | |
| QYKSHFVAASLSNQK | 706 | Q86XP3 | |
| NFSINYKNERNFSKH | 86 | Q6ZWH5 | |
| KHFTVNKNFLSNYSR | 1511 | O15018 | |
| NFNAKYVSLHVRKSN | 101 | P41227 | |
| TLNRYSNFYNKSQSH | 1421 | Q14999 | |
| FQYLHQKQFLHRKFS | 821 | Q8TET4 | |
| NKFSHFYRRQKQLES | 411 | Q9ULS6 | |
| QNSNHTFYLFKVLKA | 76 | Q8N136 | |
| HTVDFTFNKFNKSYN | 781 | P18084 | |
| IFNHSQRTLAYKANK | 376 | Q5T6X5 | |
| FSRTFNDHKQKYLQL | 146 | O00461 | |
| GSFFRSKSYLNKHIQ | 611 | Q9HBE1 | |
| IKNYFQHREFSFTLK | 36 | P49642 | |
| NNFEYTKRKTFLRTH | 1511 | Q5JSL3 | |
| FFSRVYNLHQKNGFT | 46 | Q7Z3C6 | |
| VNFPSAKQYFSQFKH | 51 | Q8WWM9 | |
| HLKRYASVKNQFNFP | 471 | Q49MI3 | |
| NFFRSYKNNTLKLNS | 241 | Q9C0D9 | |
| KNFASNHIQLQKYAR | 336 | Q17RY0 | |
| HSFSFYELKNVTNNF | 166 | Q9NWZ3 | |
| FFGSSKIKHARVYNN | 261 | Q6ZTR5 | |
| FHAFLSNNRKLYKKV | 591 | Q8TB24 | |
| HTTYFTKFARQVCKN | 471 | Q9BTC8 | |
| FLSNHINSYFKRKEK | 206 | Q9NP80 | |
| FFKRTVQNNKHYTCT | 36 | Q13285 | |
| KRNFFSRHQSFTTKT | 481 | Q8N103 | |
| ESNLQDKYQSFKHFR | 341 | Q8NF91 | |
| YSPQKKNKALFHQFS | 211 | Q92565 | |
| NFKNVNFTTIQRKYF | 231 | O15457 | |
| FQQFRKSKENNIFYS | 16 | P29508 | |
| RKKHLNYTEFTQFLQ | 141 | O75746 | |
| IRKQSVNYFKNYHRT | 441 | Q96JG6 | |
| FNSFFHRQLVTKGYN | 606 | Q96HI0 | |
| VFHKFSNSNKDKIRY | 151 | Q3SXZ3 | |
| SSVKSHILNKYRNDF | 151 | Q6PDB4 | |
| KAFSHAQYFQKHVRS | 471 | Q15935 | |
| GKAFTYRSNFVLHNK | 286 | Q14592 | |
| FSKFSNSNRHNARYT | 166 | P0CB33 | |
| ASKFAQHAFRTFDKN | 61 | P62760 | |
| NFNAKYVSLHVRKSN | 101 | Q9BSU3 | |
| LSFNYQKRVSFAHLS | 341 | Q9NR96 | |
| NFDQYRKVFTHSSLL | 161 | Q14586 | |
| NKSFKYFSQLSIHRR | 361 | A6NJL1 | |
| LSSHFKVFRVYASNQ | 1076 | Q96K76 | |
| FKYRSNFTKHQKTHS | 426 | A6NDX5 | |
| KSFSQNFSLIYHQRV | 376 | Q13398 | |
| FSVKTHIFNNYRNDF | 166 | Q76KX8 | |
| FQQFRKSKENNIFYS | 16 | P48594 | |
| ATNIQRKYLKHQTFA | 1531 | P02549 | |
| FDTIQRSKNHYQKRA | 2371 | O00507 | |
| KSTHGQLRTDKNYSF | 496 | Q96JH7 | |
| FNFSHFKDYRKLSQE | 336 | Q14166 | |
| AAYSQFFHSLFTQNK | 36 | Q9UFB7 | |
| NSNRDKTRYTGNKHF | 171 | Q96JC4 | |
| KTFNYNKAQSHQLFA | 316 | Q7Z4N2 | |
| KVFSYNSNFARHQRI | 266 | Q8WV37 | |
| TFNYSSNFTNHKKIH | 456 | P17019 | |
| FYKFSNPNIQKIRHT | 186 | Q9H8G1 | |
| DKYVKVFHKFSNSNR | 116 | Q9P255 | |
| KVFHKFSNSNTYKTR | 151 | O75346 | |
| KTFKYNSDLSRHQRS | 216 | Q9BRH9 | |
| DFENTSKFSKHKRNY | 626 | Q96N22 | |
| FKAHKNVLAAFSQYF | 36 | Q6ZSB9 | |
| NYENNFFHSSLLTLK | 206 | A6NHJ4 | |
| FKTQSNLYKHRRTQT | 181 | Q5JPB2 | |
| TQHYSIGLRQKNSFK | 6 | Q14679 | |
| GKVFKYNSSFISHQR | 136 | Q8NCK3 | |
| NNLKKYNLFSVSNHY | 1046 | P40818 | |
| KSFSKYVSFSNHQRV | 276 | B7Z6K7 | |
| KSFSKYASFSNHQRV | 331 | B7Z6K7 | |
| GKSFSKYASFSNHQR | 386 | B7Z6K7 | |
| KYGKNFLHSSFTQIQ | 206 | Q0VGE8 | |
| QKLYDRHSSSQHFQK | 526 | Q9ULV0 |